| MD-2 is required for disulfide HMGB1–dependent TLR4 signaling H Yang, H Wang, Z Ju, AA Ragab, P Lundbäck, W Long, SI Valdes-Ferrer, ... Journal of Experimental Medicine 212 (1), 5-14, 2015 | 367 | 2015 |
| C1q and HMGB1 reciprocally regulate human macrophage polarization M Son, A Porat, M He, J Suurmond, F Santiago-Schwarz, U Andersson, ... Blood, The Journal of the American Society of Hematology 128 (18), 2218-2228, 2016 | 150 | 2016 |
| High mobility group box 1 orchestrates tissue regeneration via CXCR4 M Tirone, NL Tran, C Ceriotti, A Gorzanelli, M Canepari, R Bottinelli, ... Journal of Experimental Medicine 215 (1), 303-318, 2018 | 138 | 2018 |
| Identification of CD163 as an antiinflammatory receptor for HMGB1-haptoglobin complexes H Yang, H Wang, YA Levine, MK Gunasekaran, Y Wang, M Addorisio, ... JCI insight 1 (7), 2016 | 114 | 2016 |
| Pomalidomide reverses γ-globin silencing through the transcriptional reprogramming of adult hematopoietic progenitors. LB Brian M Dulmovits, Abena O Appiah-Kubi, Julien Papoin, John Hale, Mingzhu ... Blood. 127 (11), 1481 - 1492, 2015 | 107* | 2015 |
| Inhibition of HMGB1/RAGE-mediated endocytosis by HMGB1 antagonist box A, anti-HMGB1 antibodies, and cholinergic agonists suppresses inflammation H Yang, H Liu, Q Zeng, GH Imperato, ME Addorisio, J Li, M He, KF Cheng, ... Molecular Medicine 25, 1-13, 2019 | 103 | 2019 |
| Exploring the biological functional mechanism of the HMGB1/TLR4/MD-2 complex by surface plasmon resonance M He, ME Bianchi, TR Coleman, KJ Tracey, Y Al-Abed Molecular Medicine 24, 1-9, 2018 | 82 | 2018 |
| Connexin 43 hemichannel as a novel mediator of sterile and infectious inflammatory diseases W Li, G Bao, W Chen, X Qiang, S Zhu, S Wang, M He, G Ma, M Ochani, ... Scientific Reports 8 (1), 166, 2018 | 70 | 2018 |
| Identification of iguratimod as an inhibitor of macrophage migration inhibitory factor (MIF) with steroid-sparing potential J Bloom, C Metz, S Nalawade, J Casabar, KF Cheng, M He, B Sherry, ... Journal of Biological Chemistry 291 (51), 26502-26514, 2016 | 64 | 2016 |
| Correcting Smad1/5/8, mTOR, and VEGFR2 treats pathology in hereditary hemorrhagic telangiectasia models S Ruiz, H Zhao, P Chandakkar, J Papoin, H Choi, A Nomura-Kitabayashi, ... The Journal of clinical investigation 130 (2), 942-957, 2020 | 63 | 2020 |
| Evidence supporting the use of peptides and peptidomimetics as potential SARS-CoV-2 (COVID-19) therapeutics S VanPatten, M He, A Altiti, K F Cheng, MH Ghanem, Y Al-Abed Future medicinal chemistry 12 (18), 1647-1656, 2020 | 62 | 2020 |
| Generation of a unique small molecule peptidomimetic that neutralizes lupus autoantibody activity O Bloom, KF Cheng, M He, A Papatheodorou, BT Volpe, B Diamond, ... Proceedings of the National Academy of Sciences 108 (25), 10255-10259, 2011 | 59 | 2011 |
| Studies on the diastereoselective reductive alkylation of (R)-phenylglycinol derived phthalimide: observation of stereoelectronic effects MD Chen, MZ He, X Zhou, LQ Huang, YP Ruan, PQ Huang Tetrahedron 61 (5), 1335-1344, 2005 | 57 | 2005 |
| A versatile approach for the asymmetric synthesis of 3-alkyl-2, 3-dihydro-1H-isoindolin-1-ones MD Chen, X Zhou, MZ He, YP Ruan, PQ Huang Tetrahedron 60 (7), 1651-1657, 2004 | 56 | 2004 |
| Inhibition of IRF5 hyperactivation protects from lupus onset and severity S Song, S De, V Nelson, S Chopra, M LaPan, K Kampta, S Sun, M He, ... The Journal of clinical investigation 130 (12), 6700-6717, 2020 | 53 | 2020 |
| Extracellular micro RNA 130b‐3p inhibits eCIRP‐induced inflammation SD Gurien, M Aziz, H Jin, H Wang, M He, Y Al‐Abed, JM Nicastro, ... EMBO reports 21 (1), e48075, 2020 | 49 | 2020 |
| Lopinavir-NO, a nitric oxide-releasing HIV protease inhibitor, suppresses the growth of melanoma cells in vitro and in vivo S Paskas, E Mazzon, MS Basile, E Cavalli, Y Al-Abed, M He, S Rakocevic, ... Investigational New Drugs 37, 1014-1028, 2019 | 47 | 2019 |
| The cation channel Trpv2 is a new suppressor of arthritis severity, joint damage, and synovial fibroblast invasion T Laragione, KF Cheng, MR Tanner, M He, C Beeton, Y Al-Abed, ... Clinical immunology 158 (2), 183-192, 2015 | 41 | 2015 |
| DNA-mediated interferon signature induction by SLE serum occurs in monocytes through two pathways: a mechanism to inhibit both pathways A Porat, E Giat, C Kowal, M He, M Son, E Latz, I Ben-Zvi, Y Al-Abed, ... Frontiers in immunology 9, 2824, 2018 | 35 | 2018 |
| HMGB1-mediated restriction of EPO signaling contributes to anemia of inflammation BM Dulmovits, Y Tang, J Papoin, M He, J Li, H Yang, ME Addorisio, ... Blood, The Journal of the American Society of Hematology 139 (21), 3181-3193, 2022 | 29 | 2022 |
